ADiTx Therapeutics Inc. (ADTX) News
Filter ADTX News Items
ADTX News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
ADTX News Highlights
- For ADTX, its 30 day story count is now at 2.
- Over the past 14 days, the trend for ADTX's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
Latest ADTX News From Around the Web
Below are the latest news stories about ADITXT INC that investors may wish to consider to help them evaluate ADTX as an investment opportunity.
Aditxt First Quarter 2023 Earnings: US$1.31 loss per share (vs US$6.80 loss in 1Q 2022)Aditxt ( NASDAQ:ADTX ) First Quarter 2023 Results Key Financial Results Revenue: US$218.4k (up 3.9% from 1Q 2022). Net... |
Aditxt Subsidiary Adimune Signs Clinical Trial Agreement with Top Research Institution to Study Stiff Person SyndromeRICHMOND, Va., May 05, 2023--Aditxt®, Inc. announces that its subsidiary Adimune,™ Inc. has signed a clinical trial agreement with Mayo Clinic to study Stiff Person Syndrome. |
Aditxt Announces Closing of $1.9 Million Registered Direct Offering Priced At-The-Market under Nasdaq RulesRICHMOND, Va., April 24, 2023--Aditxt, Inc., (NASDAQ: ADTX) ("Aditxt" or the "Company"), an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announced the closing of its previously announced registered direct offering with a single healthcare-focused institutional investor for the purchase and sale of an aggregate of 1,585,350 shares of common stock (or common stock equivalents in lieu thereof) at a purchase price o |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on FridayIt's time for a dive into the latest stock market happenings with the biggest pre-market stock movers worth watching on Friday! |
Aditxt Announces $1.9 Million Registered Direct Offering Priced At-The-Market under Nasdaq RulesRICHMOND, Va., April 20, 2023--Aditxt, Inc. (NASDAQ: ADTX) ("Aditxt" or the "Company"), an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announced that it has entered into a definitive agreement with a single healthcare-focused institutional investor for the purchase and sale of an aggregate of 1,585,350 shares of common stock (or common stock equivalents in lieu thereof) at a purchase price of $1.22 per share (o |
Aditxt Signs Asset Purchase Agreement to Acquire Fifty Percent Ownership of Global Response Aid – with Rights to Manufacture and Market Broad-Spectrum Antiviral Drug AviganRICHMOND, Va., April 20, 2023--Aditxt,® Inc. (NASDAQ: ADTX) ("Aditxt" or the "Company"), a global innovation company focused on therapeutics and technologies that monitor and modulate the immune system, is pleased to announce the signing of an asset purchase agreement with Cellvera, Ltd. ("Cellvera") that grants Aditxt (whether directly or in its recently formed wholly owned subsidiary Adivir, ™ Inc. ("Adivir"), a 50% ownership in G Response Aid FZE ("GRA" or "Global Response Aid") with the othe |
Aditxt Issues Shareholder UpdateRICHMOND, Va, April 17, 2023--Aditxt,® Inc, (NASDAQ: ADTX) ("Aditxt" or the "Company"), a global innovation company focused on therapeutics and technologies that monitor and modulate the immune system, is pleased to provide an important update regarding its three innovation programs and strategic M&A initiatives. |
Aditxt Names Media Industry Veteran Maureen Connolly as Chief Content and Engagement OfficerRICHMOND, Va., March 08, 2023--Aditxt, Inc., (NASDAQ: ADTX) ("Aditxt" or the "Company"), an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, is pleased to announce Maureen Connolly has joined Aditxt as Chief Content and Engagement Officer. Connolly is an award-winning content strategist and audience builder with 25+ years of experience in the health, science, wellness, technology, and chronic conditions space. She works w |
Aditxt Retains Riverside Management Group as Advisor to Support Strategic M&A Driven Acquisitions by Subsidiary Pearsanta, Inc.RICHMOND, Va., March 03, 2023--Aditxt, Inc., (NASDAQ: ADTX) ("Aditxt" or the "Company"), an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announces it has retained Riverside Management Group, LLC ("Riverside Management Group" or "RMG"), a merchant banking firm providing investment banking advisory services, to support the Company’s ongoing growth and revenue generating plans for its subsidiary Pearsanta, Inc. ("P |
Aditxt Forms its Second Subsidiary, Pearsanta, Inc., to Accelerate the Growth of its AditxtScore™ Program and Appoints Healthcare Executive and Current Head of AditxtScore™ Anthony Voorhies to Serve as its PresidentRICHMOND, Va., February 14, 2023--Aditxt, Inc., (NASDAQ: ADTX) ("Aditxt" or the "Company"), an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announces the formation of a U.S.-based wholly- owned subsidiary, Pearsanta, Inc. ("Pearsanta"), to accelerate the growth of Aditxt’s second program, AditxtScore™, through future strategic revenue and growth-oriented transactions. |